Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03602066 · ClinicalTrials.gov registry record · Phase 2
Study Evaluating The Role of ClO2 on Mucositis for Pt. Undergoing Head/Neck Radiotherapy
A Phase 2 study, sponsored by University of Arizona.
- Terminated
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT03602066 is a Phase 2 study that was terminated before completion, run by University of Arizona. The registered enrollment target is 14 participants.
The verdict
NCT03602066, a Phase 2 study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
This pilot randomized phase II trial studies who well chlorine dioxide sterilization works in reducing oral mucositis in patients with stage I-IV head and neck cancer who are undergoing radiotherapy. Chlorine dioxide sterilization may help to treat oral mucositis.
Interventions
- OTHER Placebo
- OTHER Laboratory Biomarker Analysis
- DRUG Chlorine Dioxide Sterilization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-02-14 |
| Est. Completion | 2022-11-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03602066
The ClinicalTrials.gov registry entry for NCT03602066 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03602066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03602066 about?
NCT03602066 is a clinical study titled "Study Evaluating The Role of ClO2 on Mucositis for Pt. Undergoing Head/Neck Radiotherapy". This pilot randomized phase II trial studies who well chlorine dioxide sterilization works in reducing oral mucositis in patients with stage I-IV head and neck cancer who are undergoing radiotherapy. Chlorine dioxide sterilization may help to treat oral mucositis.
What is the current status of trial NCT03602066?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2019-02-14. Estimated completion is 2022-11-07.
What interventions are being tested in trial NCT03602066?
The interventions under investigation include: Placebo (OTHER), Laboratory Biomarker Analysis (OTHER), Chlorine Dioxide Sterilization (DRUG).
Who is sponsoring clinical trial NCT03602066?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.